US 7175981
Method of diagnosing stage or aggressiveness of breast and prostate cancer based on levels of fatty acid binding proteins
granted A61KA61K33/24
Quick answer
US patent 7175981 (Method of diagnosing stage or aggressiveness of breast and prostate cancer based on levels of fatty acid binding proteins) held by The United States of America as represented by the Secretary of the Army expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Army
- Grant date
- Tue Feb 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K33/24